Studies have shown that FGF2 increases the permeability of endothelial tight junctions and upregulates ICAM-1 and VCAM-1 expression, providing favorable conditions for circulating tumor cell adhesion and transendothelial migration [163,164]. Here, FGF2 is linked to neoplasm.